NUVB
Nuvation Bio Inc.
$4.92
+3.36%
$1.7B
No data for this timeframe.
Vol
Market Cap$1.7B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders50 funds
Inst. Value$553.3M
Inst. Activity17 buys / 12 sells
Insider Activity1B / 3S
Insider Net $-$1.2M
Reddit Sentiment63° Warm
SEC Reports3
Recent Activity
Jun 11, 2026
short_volume
Short Volume: NUVB — 55.5% short (0.7M / 1.3M)
Short: 700,140 | Exempt: 11,228 | TRF Vol: 1,262,416 | Short Ratio: 55.5% | Off-exchange volume (dar
Jun 9, 2026
Insider
Mashal Robert bought 25,000 shares
Director @ $4.73 ($118.3K)
May 21, 2026
Insider
FALBERG KATHRYN E was granted 123,397 shares
Director
May 21, 2026
Insider
Mashal Robert was granted 123,397 shares
Director
May 4, 2026
SEC
Nuvation Bio reported Q1 2026 total revenue of $83.2M (up from $3.1M YoY) and net income of $5.4M ($0.01 diluted EPS) vs
8-K — Impact 6/10
Apr 21, 2026
SEC
Nuvation Bio Inc. filed a supplemental proxy statement to correct a typographical error in the non-employee director com
DEFA14A — Impact 2/10
Apr 17, 2026
SEC
Kerry Wentworth, an officer of Nuvation Bio Inc., filed a Form 144 to sell up to 36,750 shares of common stock, valued a
144 — Impact 3/10
Inst.
MORGAN STANLEY — ADD
1,871,217 shares ($8.0M)
Price Targets
$12.33
+150.7% upside
Strong Buy
Current $4.92
Low $7.00
Median $12.00
High $20.00
9 analysts
$7.00
$20.00
Analyst Ratings
4Strong Buy
11Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 5, 2026 | RBC Capital | REITERATE | Outperform → Outperform |
| May 5, 2026 | Wedbush | REITERATE | Outperform → Outperform |
| May 5, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Apr 16, 2026 | Wedbush | REITERATE | Outperform → Outperform |
| Apr 2, 2026 | Wedbush | REITERATE | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.12 ▼ -9.1% | $-0.12 — $-0.12 | 13% YoY | 1 |
| Next Q | $-0.11 ▼ -22.2% | $-0.11 — $-0.11 | 21% YoY | 1 |
| Current FY | $-0.28 ▼ -27.3% | $-0.28 — $-0.28 | 43% YoY | 1 |
| Next FY | $-0.06 ▲ +58.6% | $-0.06 — $-0.06 | 79% YoY | 1 |
Latest Reports
MIXED
8-K
6/10
Nuvation Bio reported Q1 2026 total revenue of $83.2M (up from $3.1M YoY) and net income of $5.4M ($0.01 diluted EPS) vs
May 4, 2026
NEUTRAL
DEFA14A
2/10
Nuvation Bio Inc. filed a supplemental proxy statement to correct a typographical error in the non-employee director com
Apr 21, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| FMR LLC | $223.0M | — |
| BlackRock, Inc. | $107.7M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.9M | — |
| STATE STREET CORP | $29.1M | — |
| BANK OF AMERICA CORP | $13.8M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 9, 2026 | Mashal Robert | BUY | $118.3K |
| May 21, 2026 | FALBERG KATHRYN | A | $0.00 |
| May 21, 2026 | Mashal Robert | A | $0.00 |
| May 21, 2026 | Cui Xiangmin | A | $0.00 |
| May 21, 2026 | Bazemore Robert | A | $0.00 |
Reddit Sentiment
63°
Warm
Bearish
Neutral
Bullish
50 institutional holders with $553.3M total value (128,707,080 shares) as of 2026-Q1. Top holders: FMR, BlackRock,, VANGUARD. Net buying activity: 17 institutions added/increased vs 12 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | FMR LLC | 51,989,593 | $223.0M | 40.3% | — |
| 2 | BlackRock, Inc. | 25,100,374 | $107.7M | 19.5% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 11,626,198 | $49.9M | 9.0% | — |
| 4 | STATE STREET CORP | 6,784,927 | $29.1M | 5.3% | — |
| 5 | BANK OF AMERICA CORP /DE/ | 3,219,826 | $13.8M | 2.5% | DOUBLED +505.5% |
| 6 | TWO SIGMA INVESTMENTS, LP | 2,684,089 | $11.5M | 2.1% | TRIM -69.0% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2,275,446 | $9.8M | 1.8% | — |
| 8 | CITADEL ADVISORS LLC | 2,065,411 | $8.9M | 1.6% | — |
| 9 | DIMENSIONAL FUND ADVISORS LP | 2,052,691 | $8.8M | 1.6% | TRIM -37.8% |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,992,451 | $8.5M | 1.5% | — |
| 11 | GOLDMAN SACHS GROUP INC | 1,929,953 | $8.3M | 1.5% | — |
| 12 | MORGAN STANLEY | 1,871,217 | $8.0M | 1.5% | ADD +46.6% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 1,592,449 | $6.8M | 1.2% | — |
| 14 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,439,357 | $6.2M | 1.1% | ADD +75.6% |
| 15 | ABRAMS CAPITAL MANAGEMENT, L.P. | 1,270,504 | $5.5M | 1.0% | TRIM -66.7% |
| 16 | Connor, Clark & Lunn Investment Management Ltd. | 1,207,771 | $5.2M | 0.9% | DOUBLED +529.1% |
| 17 | Woodline Partners LP | 960,414 | $4.1M | 0.7% | — |
| 18 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 724,383 | $3.1M | 0.6% | — |
| 19 | WELLINGTON MANAGEMENT GROUP LLP | 672,144 | $2.9M | 0.5% | TRIM -25.3% |
| 20 | Beacon Pointe Advisors, LLC | 643,734 | $2.8M | 0.5% | DOUBLED +148.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 1,276,128 | 1,871,217 | +46.6% | $8.0M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 819,632 | 1,439,357 | +75.6% | $6.2M | 2026-Q1 |
| ABRAMS CAPITAL MANAGEMENT, L.P. | TRIM | 3,811,513 | 1,270,504 | -66.7% | $5.5M | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | DOUBLED | 191,998 | 1,207,771 | +529.1% | $5.2M | 2026-Q1 |
| WELLINGTON MANAGEMENT GROUP LLP | TRIM | 899,988 | 672,144 | -25.3% | $2.9M | 2026-Q1 |
| Beacon Pointe Advisors, LLC | DOUBLED | 259,212 | 643,734 | +148.3% | $2.8M | 2026-Q1 |
| Nuveen, LLC | NEAR_EXIT | 2,852,001 | 514,117 | -82.0% | $2.2M | 2026-Q1 |
| Invesco Ltd. | TRIM | 1,185,143 | 437,806 | -63.1% | $1.9M | 2026-Q1 |
| STATE OF WISCONSIN INVESTMENT BOARD | ADD | 256,986 | 378,157 | +47.2% | $1.6M | 2026-Q1 |
| Russell Investments Group, Ltd. | DOUBLED | 24,456 | 265,700 | +986.4% | $1.1M | 2026-Q1 |
| ExodusPoint Capital Management, LP | DOUBLED | 60,308 | 163,687 | +171.4% | $702.2K | 2026-Q1 |
| FRANKLIN RESOURCES INC | DOUBLED | 184 | 118,593 | +64352.7% | $508.8K | 2026-Q1 |
| CAPSTONE INVESTMENT ADVISORS, LLC | DOUBLED | 14,152 | 112,170 | +692.6% | $481.2K | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 278,831 | 104,682 | -62.5% | $449.1K | 2026-Q1 |
| MARSHALL WACE, LLP | NEAR_EXIT | 1,234,273 | 103,546 | -91.6% | $444.2K | 2026-Q1 |
| SEI INVESTMENTS CO | TRIM | 84,166 | 43,203 | -48.7% | $185.3K | 2026-Q1 |
| VOYA INVESTMENT MANAGEMENT LLC | TRIM | 99,780 | 41,989 | -57.9% | $180.1K | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | DOUBLED | 14,290 | 37,030 | +159.1% | $158.9K | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | DOUBLED | 4,800 | 36,100 | +652.1% | $154.9K | 2026-Q1 |
| Amundi | DOUBLED | 12,814 | 36,072 | +181.5% | $154.7K | 2026-Q1 |
| TD ASSET MANAGEMENT INC | NEAR_EXIT | 312,400 | 30,462 | -90.2% | $130.7K | 2026-Q1 |
| HighTower Advisors, LLC | ADD | 22,457 | 28,198 | +25.6% | $121.0K | 2026-Q1 |
| M&T BANK CORP | DOUBLED | 3,312 | 22,758 | +587.1% | $97.6K | 2026-Q1 |
| Trexquant Investment LP | NEAR_EXIT | 186,887 | 21,559 | -88.5% | $92.5K | 2026-Q1 |
| Swiss Life Asset Management Ltd | ADD | 11,254 | 15,762 | +40.1% | $67.6K | 2026-Q1 |
15 unique insiders with 25 transactions. Net insider value: -$1.2M ($118.3K bought, $1.3M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Mashal Robert | Director | BUY | 25,000 | $4.73 | $118.3K |
| May 21, 2026 | FALBERG KATHRYN E | Director | AWARD | 123,397 | — | — |
| May 21, 2026 | Mashal Robert | Director | AWARD | 123,397 | — | — |
| May 21, 2026 | Cui Xiangmin | Director | AWARD | 123,397 | — | — |
| May 21, 2026 | Bazemore Robert B | Director | AWARD | 123,397 | — | — |
| May 21, 2026 | BLICKENSTAFF KIM D | Director | AWARD | 123,397 | — | — |
| May 21, 2026 | VERNON W ANTHONY | Director | AWARD | 123,397 | — | — |
| Apr 17, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | EXERCISE | 50,000 | $1.94 | $97.0K |
| Apr 17, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | SELL | 50,000 | $5.02 | $251.0K |
| Apr 17, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | EXERCISE | 36,750 | $2.93 | $107.7K |
| Apr 17, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | SELL | 36,750 | $5.01 | $184.3K |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | EXERCISE | 100,000 | $1.87 | $187.0K |
| Apr 6, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | SELL | 200,000 | $4.52 | $903.6K |
| Feb 27, 2026 | Cui Xiangmin | Director | AWARD | 76,923 | — | — |
| Feb 27, 2026 | Makunje Moses | SEE REMARKS | AWARD | 50,761 | — | — |
| Feb 27, 2026 | Makunje Moses | SEE REMARKS | AWARD | 224,439 | — | — |
| Feb 27, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | AWARD | 748,130 | — | — |
| Feb 27, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | AWARD | 748,130 | — | — |
| Feb 27, 2026 | Sjogren Colleen | Chief Commercial Officer | AWARD | 748,130 | — | — |
| Feb 27, 2026 | Sauvage Philippe | Chief Financial Officer | AWARD | 748,130 | — | — |
| Feb 27, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | AWARD | 748,130 | — | — |
| Feb 27, 2026 | Cui Xiangmin | Director | AWARD | 74,813 | — | — |
| Feb 27, 2026 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | AWARD | 748,130 | — | — |
| Feb 27, 2026 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | AWARD | 748,130 | — | — |
| Feb 27, 2026 | Hung David | PRESIDENT AND CEO | AWARD | 1,995,012 | — | — |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 3.7/10.
MIXED
8-K
6/10
Nuvation Bio reported Q1 2026 total revenue of $83.2M (up from $3.1M YoY) and net income of $5.4M ($
May 4, 2026
NEUTRAL
DEFA14A
2/10
Nuvation Bio Inc. filed a supplemental proxy statement to correct a typographical error in the non-e
Apr 21, 2026
NEUTRAL
144
3/10
Kerry Wentworth, an officer of Nuvation Bio Inc., filed a Form 144 to sell up to 36,750 shares of co
Apr 17, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (88% buy). Based on 17 analysts: 4 strong buy, 11 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$12.33 mean target
+150.7% upside
Strong Buy (1.40)
$7.00 Low
$20.00 High
| Metric | Value |
|---|---|
| Current Price | $4.92 |
| Target Low | $7.00 |
| Target Mean | $12.33 |
| Target Median | $12.00 |
| Target High | $20.00 |
| # Analysts | 9 |
| Recommendation | Strong Buy (1.40) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.12 | $-0.12 | $-0.12 | 13.0% | -9.1% | 0↑ 1↓ | $0.0B | 474.0% | 1 |
| Next Q 2026-09-30 |
$-0.11 | $-0.11 | $-0.11 | 21.1% | -22.2% | 0↑ 1↓ | $0.0B | 201.1% | 1 |
| Current FY 2026-12-31 |
$-0.28 | $-0.28 | $-0.28 | 43.3% | -27.3% | 0↑ 1↓ | $0.2B | 222.1% | 1 |
| Next FY 2027-12-31 |
$-0.06 | $-0.06 | $-0.06 | 78.6% | +58.6% | 0↑ 1↓ | $0.3B | 43.3% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.120 | |
| 7d ago | $-0.110 | -0.010 |
| 30d ago | $-0.110 | -0.010 |
| 60d ago | $-0.100 | -0.020 |
| 90d ago | $0.000 | -0.120 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 5, 2026 | RBC Capital | REITERATE | Outperform | Outperform |
| May 5, 2026 | Wedbush | REITERATE | Outperform | Outperform |
| May 5, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 16, 2026 | Wedbush | REITERATE | Outperform | Outperform |
| Apr 2, 2026 | Wedbush | REITERATE | Outperform | Outperform |
| Mar 27, 2026 | Wedbush | REITERATE | Outperform | Outperform |
| Mar 3, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Mar 3, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Feb 10, 2026 | Wedbush | REITERATE | Outperform | Outperform |
| Jan 21, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Jan 12, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Jan 7, 2026 | UBS | INITIATE | — | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% | |
| May 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% | |
| Apr 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% | |
| Mar 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% | |
| Feb 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% | |
| Jan 1, 2026 | 4 | 11 | 1 | 0 | 0 | 94% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
63°
Warm
Bearish
Neutral
Bullish
4 mentions
2 bullish
0 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 4, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Jun 4, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 5, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 5, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Why NUVB is a gem - in the low 5's.
▲ 1
💬 0
⚡ 0.5
Gambling my 401k/Roth from 10k -> $2M ($DOCN & others)
▲ 1
💬 1
⚡ 0.5
Jun 11, 2026
short_volume
Short Volume: NUVB — 55.5% short (0.7M / 1.3M)
Short: 700,140 | Exempt: 11,228 | TRF Vol: 1,262,416 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
Jun 10, 2026
short_volume
Short Volume: NUVB — 70.3% short (1.8M / 2.5M)
Short: 1,776,337 | Exempt: 0 | TRF Vol: 2,527,643 | Short Ratio: 70.3% | Off-exchange volume (dark pool + OTC)
Jun 9, 2026
short_volume
Short Volume: NUVB — 71.0% short (3.3M / 4.6M)
Short: 3,289,166 | Exempt: 5,937 | TRF Vol: 4,631,359 | Short Ratio: 71.0% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
short_volume
Short Volume: NUVB — 62.1% short (0.7M / 1.2M)
Short: 749,880 | Exempt: 1,500 | TRF Vol: 1,206,807 | Short Ratio: 62.1% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: NUVB — 61.6% short (0.8M / 1.2M)
Short: 753,602 | Exempt: 5,956 | TRF Vol: 1,223,208 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: NUVB — 56.4% short (0.7M / 1.2M)
Short: 650,545 | Exempt: 162 | TRF Vol: 1,154,377 | Short Ratio: 56.4% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: NUVB — 63.8% short (1.0M / 1.6M)
Short: 1,040,108 | Exempt: 1,776 | TRF Vol: 1,630,479 | Short Ratio: 63.8% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: NUVB — 72.3% short (1.7M / 2.3M)
Short: 1,663,619 | Exempt: 4,228 | TRF Vol: 2,300,226 | Short Ratio: 72.3% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: NUVB — 64.9% short (0.9M / 1.4M)
Short: 910,715 | Exempt: 8,038 | TRF Vol: 1,402,260 | Short Ratio: 64.9% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: NUVB — 63.8% short (0.4M / 0.6M)
Short: 413,089 | Exempt: 100 | TRF Vol: 647,164 | Short Ratio: 63.8% | Off-exchange volume (dark pool + OTC)
May 27, 2026
short_volume
Short Volume: NUVB — 58.7% short (0.7M / 1.2M)
Short: 730,223 | Exempt: 59,627 | TRF Vol: 1,244,417 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: NUVB — 78.2% short (2.0M / 2.5M)
Short: 1,952,776 | Exempt: 10,217 | TRF Vol: 2,497,362 | Short Ratio: 78.2% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: NUVB — 65.9% short (1.5M / 2.3M)
Short: 1,496,879 | Exempt: 750 | TRF Vol: 2,271,543 | Short Ratio: 65.9% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: NUVB — 61.2% short (1.2M / 1.9M)
Short: 1,187,364 | Exempt: 517 | TRF Vol: 1,939,354 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: NUVB — 68.2% short (1.5M / 2.3M)
Short: 1,549,148 | Exempt: 62 | TRF Vol: 2,272,036 | Short Ratio: 68.2% | Off-exchange volume (dark pool + OTC)